Skip to content

Long-acting cabotegravir injection shows promise for HIV prevention

Raphael Landovitz at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

Ipergay trial: PrEP still protected people who had less sex and used it less often

Guillemette Antoni at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

PrEP should be given to all breastfed babies, researchers say

Bacterial vaginosis does not affect efficacy of oral PrEP in women

Sharon Hillier at CROI 2017. Photo credit: Robb Cohen Photography & Video

STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive

Matthew Golden at CROI 2017. Photo by Ben Ryan (@scribenyc)

Unique case of PrEP failure without drug resistance reported from Amsterdam

Elske Hoornenborg and Godelieve de Bree at CROI 2017. Photo by Gus Cairns, aidsmap.com

Experimental STI prophylaxis in PrEP users produces big drops in syphilis and chlamydia infections but not in gonorrhoea

Jean-Michel Molina at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

High hepatitis C prevalence seen in Amsterdam PrEP study participants

Implants and injectables: PrEP in the future